Lupin Limited

Lupin Limited, a multinational pharmaceutical company based in Mumbai, India, was established in 1968 by Dr. Desh Bandhu Gupta. Dr. Gupta's vision was to provide affordable and high-quality medicines to the masses, which has become the company's mission. Over the years, Lupin Limited has expanded globally, operating in more than 100 countries and offering a vast portfolio of 1,800 products across several therapeutic areas. The company is a leading manufacturer of anti-tuberculosis drugs and a frontrunner in cardiovascular, diabetes, asthma, and anti-infective medications. As of 2022, Lupin Limited's revenue was approximately INR 15,800 crores.

Lupin Limited's focus on research and development is evident in its 12 state-of-the-art facilities, employing more than 2,000 scientists across India, Japan, the US, and Europe. The company invests around 10% of its revenue in R&D annually, resulting in over 500 patents for its innovative products and processes. Lupin Limited is also committed to social responsibility and sustainability, with initiatives such as Lupin Human Welfare and Research Foundation, Lupin Foundation, and Lupin Research Park. Lupin Limited has received several awards and recognitions for its excellence in business, quality, ethics, and corporate governance.

Lupin Limited is a company that strives to make a difference in the lives of millions of people around the world by providing them with access to affordable and quality healthcare. Lupin Limited is a company that believes in innovation, integrity, and inclusiveness.

Foundation: 1968

Headquarters: Mumbai, Maharashtra
Website: https://www.lupin.com/